JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Japan ETF
EWJ
|
+$755M |
| 2 |
Walt Disney
DIS
|
+$687M |
| 3 |
Bank of America
BAC
|
+$524M |
| 4 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$479M |
| 5 |
Alibaba
BABA
|
+$432M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWX
Time Warner Inc
TWX
|
+$1.18B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$928M |
| 3 |
Wells Fargo
WFC
|
+$913M |
| 4 |
NXP Semiconductors
NXPI
|
+$901M |
| 5 |
Lam Research
LRCX
|
+$794M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 23.58% |
| 2 | Financials | 15.23% |
| 3 | Technology | 10.89% |
| 4 | Healthcare | 9.08% |
| 5 | Consumer Discretionary | 8.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4351
vTv Therapeutics
VTVT
$121M
| $51K | ﹤0.01% |
+266
| New | +$61.1K |
2016 Q4
0 quarters
|
|
|
JUNO
4352
DELISTED
Juno Therapeutics, Inc.
JUNO
| $51K | ﹤0.01% |
2,745
-2,447
| -47% | -$59.9K |
2014 Q4
8 quarters
|
|
|
POT
4353
PUT
DELISTED
Potash Corp Of Saskatchewan
POT
| $51K | ﹤0.01% |
+2,800
| New | +$48.5K |
2016 Q4
0 quarters
|
|
4354
Invesco Dorsey Wright Emerging Markets Momentum ETF
PIE
$261M
| $50K | ﹤0.01% |
3,409
+5
| +0.1% | +$77 |
2013 Q2
14 quarters
|
|
4355
PUT
Seagate
STX
$193B
| $50K | ﹤0.01% |
1,300
-47,700
| -97% | -$1.78M |
2016 Q2
2 quarters
|
|
|
SPHS
4356
DELISTED
Sophiris Bio, Inc.
SPHS
| $50K | ﹤0.01% |
17,953
-5,828
| -25% | -$16.5K |
2016 Q3
1 quarter
|
|
4357
State Street SPDR S&P Global Natural Resources ETF
GNR
$5.09B
| $49K | ﹤0.01% |
1,205
| – | – |
2013 Q2
14 quarters
|
|
4358
Gorman-Rupp
GRC
$2.04B
| $49K | ﹤0.01% |
1,598
-200
| -11% | -$5.65K |
2015 Q4
4 quarters
|
|
4359
iShares MSCI Global Silver and Metals Miners ETF
SLVP
$896M
| $49K | ﹤0.01% |
4,695
+4,070
| +651% | +$47.9K |
2016 Q3
1 quarter
|
|
|
MJCO
4360
DELISTED
Majesco
MJCO
| $49K | ﹤0.01% |
+8,017
| New | +$40.1K |
2016 Q4
0 quarters
|
|
|
TTPH
4361
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $49K | ﹤0.01% |
614
+561
| +1,058% | +$44.4K |
2015 Q4
4 quarters
|
|
|
WPXP
4362
DELISTED
WPX Energy, Inc.
WPXP
| $49K | ﹤0.01% |
750
| – | – |
2015 Q4
4 quarters
|
|
|
CPN
4363
DELISTED
Calpine Corporation
CPN
| $49K | ﹤0.01% |
4,315
+521
| +14% | +$6.14K |
2013 Q2
14 quarters
|
|
|
CYTR
4364
DELISTED
CytRx Corp
CYTR
| $49K | ﹤0.01% |
+22,060
| New | +$64.8K |
2016 Q4
0 quarters
|
|
4365
Adams Diversified Equity Fund
ADX
$3.22B
| $48K | ﹤0.01% |
3,803
+236
| +7% | +$3.03K |
2015 Q4
4 quarters
|
|
|
CDTX
4366
DELISTED
Cidara Therapeutics
CDTX
| $48K | ﹤0.01% |
231
-32
| -12% | -$6.65K |
2016 Q1
3 quarters
|
|
4367
PUT
Goldman Sachs
GS
$263B
| $48K | ﹤0.01% |
+200
| New | +$40.6K |
2016 Q4
0 quarters
|
|
4368
AdvisorShares Active Bear ETF
HDGE
$60M
| $48K | ﹤0.01% |
521
-9,124
| -95% | -$868K |
2015 Q3
5 quarters
|
|
|
CYOU
4369
DELISTED
Changyou.com Limited American Depositary Share
CYOU
| $48K | ﹤0.01% |
2,283
-3,353
| -59% | -$84.9K |
2015 Q4
4 quarters
|
|
|
NMRX
4370
DELISTED
Numerex Corp
NMRX
| $48K | ﹤0.01% |
+6,466
| New | +$50.2K |
2016 Q4
0 quarters
|
|
4371
First Majestic Silver
AG
$8.71B
| $47K | ﹤0.01% |
6,180
-44,347
| -88% | -$370K |
2016 Q1
3 quarters
|
|
4372
Bausch Health
BHC
$2.17B
| $47K | ﹤0.01% |
3,172
-276,951
| -99% | -$5.08M |
2013 Q2
14 quarters
|
|
4373
iShares US Basic Materials ETF
IYM
$1.13B
| $47K | ﹤0.01% |
567
+81
| +17% | +$6.55K |
2016 Q2
2 quarters
|
|
4374
OneMain Financial
OMF
$6.44B
| $47K | ﹤0.01% |
2,136
-1,222
| -36% | -$30K |
2015 Q1
7 quarters
|
|
4375
State Street SPDR Portfolio Long Term Corporate Bond ETF
SPLB
$1.15B
| $47K | ﹤0.01% |
1,782
| – | – |
2015 Q4
4 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2016 Portfolio in Review
As of Q4 2016, JP Morgan Chase held 5,367 positions worth $416B, up 2.4% from $406B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q4 2016 filing shows 820 new, 2,303 increased, 1,465 reduced and 328 closed positions. Its largest new stake was Yum China: 5,504,052 shares worth $144M. The largest sale was Time Warner Inc, an estimated $1.18B.
By sector, the portfolio is most concentrated in Miscellaneous at 24% of assets, up from 23% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q4 2016 buy was Yum China: 5,504,052 shares worth $144M.
- JP Morgan Chase added most to iShares MSCI Japan ETF in Q4 2016, an estimated $755M increase.
- JP Morgan Chase's biggest Q4 2016 reduction was Time Warner Inc, cutting an estimated $1.18B.
- JP Morgan Chase fully exited LinkedIn Corporation in Q4 2016, selling an estimated $149M.
- JP Morgan Chase's ten largest holdings make up 17% of its $416B portfolio in Q4 2016.
- JP Morgan Chase opened 820 new positions and closed 328 in Q4 2016.
- JP Morgan Chase's portfolio value rose 2.4% quarter-over-quarter to $416B.
Based on JP Morgan Chase's 13F filing for Q4 2016, filed 6 Feb 2017.